2014 Archived Content
Thank you to all who attended this year!
250+ R&D teams gathered in Boston this past October to discover solutions to refine early-stage drug discovery using 3D models and phenotypic screening. Did you miss this past event? Reserve your copy of the conference proceedings CD to access the speaker slides and poster abstracts our delegates received on-site.
We will soon begin working on the 2015 program agenda. If you are interested in speaking, please contact Mary Ann Brown at email@example.com.
To secure a sponsorship or exhibit package for 2015, contact Ilana Quigley at firstname.lastname@example.org.
Mark Your Calendar
Functional Analysis & Screening Technologies Congress
November 9-11, 2015
Renaissance Waterfront Hotel
Bookmark our website to stay tuned about details on the 2015 congress.
Geraldine A. Hamilton, Ph.D.
Senior Staff Scientist, Wyss Institute for Biologically Inspired Engineering, Harvard University
Jing Li, Ph.D.
Director, Genomics and Phenotypic Screening, Merck
Alan H. Wells, M.D., D.M.Sc.
Vice Chair and Thomas J. Gill III Professor, Pathology, University of Pittsburgh
John P. Wikswo, Ph.D.
Founding Director, Vanderbilt Institute for Integrative Biosystems Research and Education and Gordon A. Cain University Professor, Vanderbilt University
George Church, Ph.D.
Professor, Health Sciences and Technology, Harvard and MIT; Founding Core Faculty Member, Wyss Institute for Biologically Inspired Engineering, Harvard University
Director, Reagents and Assay Development, AstraZeneca
Kristin Fabre, Ph.D.
Scientific Program Manager, NCATS, National Institutes of Health
Meir Glick, Ph.D.
Head, In Silico Lead Discovery, Center for Proteomic Chemistry, Novartis